Post-market Clinical Follow-up Study of Alcon PRECISION1™ Spherical and PRECISION1™ for Astigmatism Soft Contact Lenses
NCT ID: NCT06462456
Last Updated: 2025-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
140 participants
OBSERVATIONAL
2024-08-30
2025-03-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)
NCT06408649
Clinical Comparison of Two Daily Disposable Toric Soft Contact Lenses
NCT05483127
Clinical Performance of Two Daily Disposable Toric Soft Contact Lenses
NCT04908488
Clinical Comparison of Toric Contact Lenses Fit Characteristics
NCT05805345
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Multifocal Toric Contact Lenses
NCT06461455
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Baseline Visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a PRECISION1™ sphere or toric contact lens prescription was released. The Baseline Visit will be retrospective, with all assessments obtained from chart review.
The Year 1 Visit is defined as the visit that occurs 1 year (-2/+4 months) since Baseline during which period the subject is wearing test lenses of the same design in both eyes and a contact lens examination is performed during the visit. The Year 1 Visit may be prospective or retrospective.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRECISION1 Sphere
Verofilcon A spherical soft contact lenses worn in both eyes in a real-world setting
Verofilcon A spherical soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)
PRECISION1 Toric
Verofilcon A toric soft contact lenses worn in both eyes in a real-world setting
Verofilcon A toric soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Verofilcon A spherical soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)
Verofilcon A toric soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Verofilcon A (sphere or toric) contact lens wear as described in the protocol.
* Best corrected spectacle distance visual acuity (VA) 20/25 or better at baseline.
* Healthy, non-diseased eyes, as determined/known by the Investigator.
Exclusion Criteria
* Use of systemic or ocular medications that would contraindicate contact lens wear at baseline.
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead, VC
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Scripps Optometric Group
San Diego, California, United States
Pearle Vision
Jacksonville, Florida, United States
Vision Health Institute
Orlando, Florida, United States
Vision Salon Eye Care Associates
Blue Island, Illinois, United States
Illinois College of Optometry
Chicago, Illinois, United States
CORL, Indiana University
Bloomington, Indiana, United States
The Eye Doctors Inc
Eden Prairie, Minnesota, United States
Cornea and Contact Lens Institute of Minnesota
Edina, Minnesota, United States
Complete Eye Care of Medina
Medina, Minnesota, United States
Spectrum Eyecare
Jamestown, New York, United States
Eyecare Professionals, Inc
Powell, Ohio, United States
Optometry Group, PLLC
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLE383-I001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.